No abstract available
MeSH terms
-
Adjuvants, Immunologic / adverse effects
-
Adjuvants, Immunologic / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Clinical Trials as Topic / adverse effects
-
Crohn Disease / complications
-
Crohn Disease / drug therapy
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
JC Virus* / isolation & purification
-
Leukoencephalopathy, Progressive Multifocal / chemically induced
-
Leukoencephalopathy, Progressive Multifocal / virology*
-
Multiple Sclerosis / complications*
-
Multiple Sclerosis / drug therapy
-
Multiple Sclerosis / virology*
-
Natalizumab
Substances
-
Adjuvants, Immunologic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunosuppressive Agents
-
Natalizumab